ASGCT News

Annual Meeting Abstract Submissions: The Why and How

We asked Paloma Giangrande, PhD, member-volunteer abstract reviewer and field expert, for her advice on submitting abstracts for the Annual Meeting. Submit by Feb. 3!

Free: Five-Minute Thesis Session & Contest

This Friday, Dec. 9, 1–3 p.m. CT, learn how to create an "elevator pitch" for your thesis and join our Five-Minute Thesis Challenge for a chance to present at the ASGCT Annual Meeting!

10 Tips to Submit Your Abstract for the ASGCT Annual Meeting

Wondering how to craft a great Annual Meeting abstract submission? Phil Tai, PhD, a member-volunteer abstract reviewer, shares his top 10 tips and considerations for researchers drafting their work. Submit by Feb. 3!

Free for Members: Research and Ethics of the Targeted Insertion of Genes into the Human Genome

Attend the expert-led session on Wednesday, Dec. 7, 1–3 p.m. CT, for free if you're a member. 

World AIDS Day: A Look Back at the Puzzle

On World AIDS day, Renee Strong, our diversity and inclusion program manager, reflects on her family's connection with the HIV/AIDS epidemic—and how the work of ASGCT member Dr. TJ Cradick became an essential part of solving the disease puzzle.

Developing a Gene Therapy for Charcot-Marie-Tooth Disease

We talked to Dr. Afrooz Rashnonejad about her experience working to develop a gene therapy for CMT1B and why patient organizations are so important in the process.

In Molecular Therapy: EBAG9 silencing exerts immune checkpoint function without adverse effects

Wirges et al demonstrate that EBAG9 downregulation in murine T cells and human CAR T cells augmented the cytolytic activity of these cells against hematopoietic tumors in vitro and in vivo.

Read Dr. Schneller's debut summary for The Vector!

FDA Approves First Gene Therapy for Hemophilia B

The approval of Hemgenix is the first of its kind for hemophilia B patients, who typically control the disease with regular infusions of the clotting factor they lack.

Free for Members: Immunological Responses to AAV Gene Therapy in Neurological Compartments

Attend the expert-led session on Wednesday, Nov. 30, 1–3 p.m. CT, for free if you're a member. 

Now On Demand: Explore the Ethical Limits of Gene Therapy

Bring your questions for Ben Hurlbut, PhD, and Krishanu Saha, PhD, who will help us break down the ethics of gene therapy.
 

Submit Your Abstract to Present at the ASGCT 26th Annual Meeting

The #ASGCT23 call for abstracts is open Nov. 15, 2022, through Feb. 3, 2023.

Take Advantage of Global Outreach Opportunities

Dr. Rao talks about some of ASGCT's recent international efforts that you can share with colleagues, watch on demand, and keep in mind to register for in the future.

Free for Members: Catch Events on Cellular Reprogramming (On Demand) & AAV Immune Responses (Nov. 30)

This month, register for Neural and Cardiac Cellular Reprogramming Nov. 16 and Immunological Responses to AAV Gene Therapy in Neurological Compartments Nov. 30.

How to Be a Champion for Health Literacy

During Health Literacy Awareness Month, learn how you can help others understand the health information they need.

Hear David Baltimore, PhD on Giants of Gene Therapy

Subscribe to the ASGCT Podcast Network to hear David Baltimore, PhD on the Nobel Prize, searching for answers on an HIV vaccine, and how gene therapy could change the course of history during his one-on-one conversation with ASGCT President Hans-Peter Kiem, MD, PhD.

Q3: Multiple First Approvals for Gene, RNA Therapies

More gene and RNA therapies were approved in Q3 than in each of the previous quarters for over a year.